Brief: Cosmo Pharmaceuticals: Canadian Agency Approval Of Eleview

Cosmo NV

01/07/2019 06:04

July 1 (Reuters) - Cosmo Pharmaceuticals NV  COPN.S :
    * 
    * ELEVIEW(R) WILL BE COMMERCIALIZED IN CANADA BY PENDOPHARM
(DIVISION OF PHARMASCIENCE INC.) UNDER AN EXISTING LICENSE AND
SUPPLY AGREEMENT

Source text for Eikon:  ID:nTEN7pi51a 
Further company coverage:  COPN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))